Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 16 Prostatic Neoplasms 4 Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Peripheral Nervous System Diseases 2 Pain 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Cardiovascular Diseases 2 Breast Carcinoma In Situ 2 Arthralgia 2 Weight Loss 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Smoldering Multiple Myeloma 1 Sarcoma 1 Radiation Injuries 1 Psoriasis 1 Polyps 1 Polycystic Ovary Syndrome 1 Pelvic Inflammatory Disease 1 Ovarian Neoplasms 1 Osteoarthritis 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1

Interventions

Cisplatin 161 Fluorouracil 135 Paclitaxel 127 Radiotherapy 125 Oxaliplatin 88 Carboplatin 72 Docetaxel 71 Irinotecan 60 pembrolizumab 57 Leucovorin 57 Capecitabine 57 Radiation 48 Esophagectomy 44 Surgical Procedures, Operative 41 Drug Therapy 38 Neoadjuvant Therapy 28 Cetuximab 25 Nivolumab 24 Bevacizumab 21 camrelizumab 20 Trastuzumab 20 S 1 (combination) 19 Chemoradiotherapy 19 Magnetic Resonance Spectroscopy 18 Epirubicin 16 Albumin-Bound Paclitaxel 16 Blood Specimen Collection 15 tislelizumab 14 Taxes 14 Radiotherapy, Intensity-Modulated 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × Fatty Acids, Omega-3 × Clear all

NCT07272382 2025-12-09

ESO-Shanghai28

Fudan University

Phase NA Recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡